The role of nitric oxide (NO) in the intestinal basal ion transport and under conditions of enterotoxin-induced ion secretion is controversial. Namely it is not clear whether NO enhances or counteracts intestinal ion secretion and whether the effects on transport result from a direct interaction with the enterocyte. The cell origin of NO is also unclear. We have tested the hypothesis that NO produced by the enterocyte directly regulates ion transport processes either in basal condition or in response to cholera toxin-induced secretion. Electrical variables reflecting transepithelial ion transport were measured in Caco-2 cell monolayers mounted in Ussing chambers exposed to the NO synthase inhibitor N-nitro-L-arginine methyl ester, in the presence or absence of cholera toxin. cAMP concentrations were also measured. NO release was determined by nitrite-nitrate concentration. NO synthase activities were assayed by Western blot analysis. N-nitro-L-arginine methyl ester had a secretory effect, as judged by increased basal short-circuit current and cAMP concentration. It also increased cholera toxin-induced electrical response and cAMP production. Either cholera toxin or the cAMP analog 8-bromo-cAMP induced a rapidly progressive and Ca 2ϩ -dependent increase in NO concentration, suggesting a homeostatic up-regulation of the constitutive form of NO synthase.
Intestinal water and electrolyte transepithelial transport is under a complex control by several agents including neurotransmitters, hormones, or paracrine agents (1) . There is evidence that NO takes part in the intestinal ion transport processes with an effect that involves the enteric nervous system, the suppression of prostaglandin formation, and the opening of K ϩ channels (2, 3) . NO is a gas with a half-life of less than 5 s, rapidly degrading to nitrite and nitrate in the presence of oxygen and water. NO is produced by a number of cells, including neuronal cells, and released in various organs. Being soluble in both water and lipids, it freely passes into adjacent target cells (2, 4) . NO is generated from L-arginine by a family of enzymes, NOS, whose activity can be stereospecifically inhibited by L-but not by D-arginine analogs (5) . Two NOS are constantly active in the intestine and are termed cNOS. They include the neuronal NOS (NOS 1) and the endothelial NOS (NOS 3). Both are Ca 2ϩ /calmodulin-dependent, produce small amounts of NO in short burst, and are involved in several homeostatic processes. A third NOS form, which is Ca 2ϩ /calmodulin-independent, is activated by various signal molecules, including proinflammatory cytokines. This latter form, termed iNOS (NOS 2), requires at least 2 h to be activated, and released NO can be measured no earlier than 3-4 h after induction. Maximal NO production by this mechanism is commonly observed 6 -24 h after induction, and peak concentration lasts 24 -72 h (2, 6, 7) . NO is thus produced by the enterocyte through both the cNOS and the iNOS forms (8, 9) .
NO may play a dual role in the intestinal ion transport processes. In physiologic conditions, the basal cNOS activity is implicated in the regulation of the proabsorptive tone in the intestine, but whether this is the result of a direct effect on the enterocyte, or involves a neurologic control of intestinal blood flow, is still not clear (2, 3) . On the contrary, an overproduction of NO by iNOS in pathologic conditions, such as inflammatory intestinal diseases, results in net ion secretion (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) .
NO appears to have some role also in stimulated secretion. In animal models, CT-induced fluid secretion was downregulated by NO (2). However, others did not detect any modification in CT-induced fluid secretion after administration of NOS inhibitors or NO donors (13) . Recently, Turvill et al. (14) hypothesized that NO has a dual role in CT-induced secretion, acting either as an absorbagogue or as a secretagogue in the rat perfused small intestine, depending on its concentration. These apparently conflicting findings are probably related to the multiple effects of NO, dose-dependent effects, and different experimental models. In the majority of studies, whole intestinal tissue was used, which contains endothelium, neurons, myocytes, mast cells, and leukocytes, all potential sources of NO. This makes it difficult to track the origin and the effects of NO in the enterocyte. The use of intestinal cell lines to study intestinal electrolyte transport would directly address these issues. Indeed, previous studies have identified both iNOS and cNOS forms in cultures of intestinal epithelium, and Caco-2 cell monolayers have been previously used for studying NO production in response to live bacteria (15) .
The aim of this study was to test the hypothesis that NO produced by the enterocyte acts as an intracellular regulator of ion transport both in basal conditions and in response to CT-induced ion secretion. We have used an in vitro model, based on Caco-2 cells, previously validated to investigate the regulation of ion transport at the cellular level and NO production (16 -18) .
METHODS
Cell culture. Caco-2 cells (code BS-TCL87) were obtained from the Istituto Zooprofilattico Sperimentale (Brescia, Italy). Cells were grown in Dulbecco's Modified Eagle's Medium (DMEM) with a high glucose concentration (4.5 g/L) supplemented with 10% FCS, 1% nonessential amino acids, penicillin (50 mU/mL), and streptomycin (50 mg/mL) and were incubated in 5% CO 2 -95% air. The medium was changed daily.
Ion transport studies. Cells were grown on uncoated polycarbonate transwell filters as previously described and used for intestinal transport studies at 15 d postconfluence (16 19. The incubation fluid was gassed with 95% O 2 -5% CO 2 and maintained at 37°C by a thermostat-regulated circulating pump. The following electrical variables were monitored by an automatic voltage-clamp (DVC 1000, World Precision Instrument) as previously described (19) , before and after the addition of CT or the NOS inhibitor L-NAME: PD, I sc , and tissue ionic G. I sc is expressed as microamperes per square centimeter (A/cm 2 ), G as millisiemens per square centimeter (mS/cm 2 ), and PD as millivolts (mV). Caco-2 cell monolayers were exposed to maximal effective doses of CT (6 ϫ 10 Ϫ8 M) added to the mucosal side in the presence or absence of a maximal effective concentration of L-NAME (2 ϫ 10 Ϫ4 M) added to both sides. CT and L-NAME maximal effective concentrations were determined by doseresponse experiments previously performed (data not shown). Cell viability was checked at the end of each experiment by measuring the I sc increase after the serosal addition of theophylline (5 mM).
Intracellular cAMP concentration. cAMP concentration in Caco-2 cells was determined by a commercial kit (Biotrak cAMP assay system; Amersham International, Amersham, U.K.), as previously described (20) . , the degradation products of NO in the culture medium, were determined by the Griess reaction after nitrate reduction as previously described (21) . Total NO 2 Ϫ /NO 3 Ϫ production is therefore referred to as NO production. Caco-2 cell monolayers were grown on plates and used at 15 d postconfluence. Experiments were also performed in Ca 2ϩ -free Ringer's solution to investigate whether cNOS, which is the Ca 2ϩ / calmodulin-dependent NOS form, rather than the iNOS form was involved. The modified Ca 2ϩ -free Ringer's solution had the following composition (in mM): Na 2 HPO 4 , 1.65; NaH 2 PO 4 , 0.3; NaHCO 3 , 15; NaCl, 53; KCl, 10; Na 2 SO 4 , 30.5; MgCl 2 , 2.35; glucose, 19; and EDTA, 0.5. In addition, to further investigate the iNOS activity as a possible source of the NO production induced by CT or by 8Br-cAMP, we performed experiments using the specific iNOS inhibitor L-NIL (0.5 M) (22) .
NOS expression. NOS expression was estimated by Western blot analysis. Caco-2 cells were exposed to CT (6 ϫ 10 Ϫ8 M) or to 8Br-cAMP (0.1 mM) for 1, 6, and 24 h. Cells were then scraped into PBS buffer and lysed in the following buffer (KCl, 60 mM; ␤-mercaptoethanol, 14 mM; EDTA, 2 mM; HEPES, pH 7.9, 15 mM; sucrose, 0.3 M; aprotinin, 5 g/mL; leupeptin, 10 g/mL; pepstatin, 2 g/mL; phenylmethylsulfonyl fluoride, 0.1 mM) containing 1% Tergitol (Nonidet P-40). Total extracts were centrifuged at 1500 ϫ g for 20 min at 4°C. Protein content was determined by the Bradford method (Bio-Rad Laboratories, Munich, Germany). The supernatant containing the solubilized proteins was boiled for 5 min in Laemmli buffer (62.5 mM Tris-HCl, pH 6.8, 2% SDS, 10% glycerol, 5% 2-mercaptoethanol, and 0.001% bromophenol blue). Cell protein (50 g/ lane) was added to SDS-PAGE and transferred to a nitrocellulose membrane (BioBlot-NC-Costar; Corning Incorporated, Canada). Blots were blocked with T-TBS buffer (Tris-HCl, pH 8.8, 10 mM; NaCl, 150 mM; Tween 20, 0.05%) containing 3% albumin, and probed for 1 h with affinity-purified anti-human NOS 1 (1:2000), NOS 2 (1:200), or NOS 3 (1:1000) rabbit polyclonal antibodies. Bound antibody was detected with anti-rabbit immunoglobulin 65 NO REGULATES ENTEROCYTE ION TRANSPORT horseradish peroxidase-linked whole antibody and developed by chemiluminescence reaction (Amersham Pharmacia Biotech, U.K.). All incubations and washes were carried out at room temperature with gentle shaking.
␥-Interferon (50,000 U/mL) was used as a positive control in experiments performed using anti-iNOS antibodies, as previously reported (17) .
Chemicals. All chemicals were of reagent grade and were obtained from Sigma Chemical Co. (St. Louis, MO, U.S.A.). Culture media were from Life Technologies (GIBCO BRL, Milan, Italy). Transwell filters and supports were from Costar (Costar Italia, Milan, Italy). Anti-cNOS and anti-iNOS polyclonal antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, U.S.A.). Anti-iNOS polyclonal antibodies were purchased from Transduction Laboratories (ABD Company, Lexington, KY, U.S.A.).
Statistical analysis. All data were expressed as mean Ϯ SD. Each experiment was run in duplicate and was repeated at least three times. Repeated-measures ANOVA was applied with Bonferroni test for multiple comparisons. The significance was set at 5%.
RESULTS
Intestinal transport studies. The simultaneous addition of L-NAME to both sides of the Caco-2 cell monolayer induced an increase in I sc . The electrical response was slow in the first 35 min, then I sc increased, with a peak 55 min after the addition of the NOS inhibitor. The increase in I sc was totally caused by an effect on PD, as no modifications of G values were recorded. The addition of CT to the luminal side of the Caco-2 cell monolayer induced a similar increase in I sc , without modifications in G. The electrical response was slow in the first 25 min, then I sc increased, with a peak 35 min after toxin addition. Preincubation of Caco-2 cells for 5 min with L-NAME produced a further increase of the CT-induced I sc rise, which was significantly greater than the sum of each individual testing molecule (Fig. 1) . cAMP determination. Intracellular cAMP concentrations were determined after 1 h of incubation with CT in the presence or absence of L-NAME. CT induced a 6-fold increase in the basal cAMP intracellular concentration. The addition of L-NAME produced a significant increase in basal cAMP. It also resulted in a further significant increase in CT-stimulated intracellular cAMP concentration. Again, the effect of CT and L-NAME was synergistic, being greater than the sum of each individual effect (Fig. 2) .
NO 2 ؊ /NO 3 ؊ concentration. One hour of incubation with CT induced an increase in NO concentration of approximately 9-fold. The effect was Ca 2ϩ -dependent, as the NO increase in response to CT addition was blunted in the absence of Ca 2ϩ . In contrast, preincubation with the specific iNOS inhibitor, L-NIL, did not prevent the CT-induced NO increase (Fig. 3) . Similar results were obtained after incubation with the cAMP analog, 8Br-cAMP, as shown in Figure 3 . 8Br-cAMP was able to induce a dose-and time-dependent NO production by the enterocyte. The maximal effect was obtained at the concentration of 0.1 mM (Fig. 4) and after 30 min of incubation (Fig. 5) . In this condition NO production did not show a further increase, indicating a saturation of the effect.
NOS expression.
Because L-NAME is a nonselective inhibitor of NOS (2), experiments were performed to assess the precise identity of NOS involved using Western blot analysis. In basal conditions cNOS (NOS 1) protein expression in Caco-2 cells was negligible, and there was no evidence of the other constitutive (NOS 3) or inducible (NOS 2) forms. Western blot analysis performed after 1 h of incubation with CT revealed stimulation of cNOS (NOS 1) protein expression, as shown by the amplification of a 160-kD band that corresponded to human NOS 1. A similar result was obtained after stimulation with 8Br-cAMP (Fig. 6) . Neither CT nor 8Br-cAMP was able to elicit NOS 2 or NOS 3 protein expression with up to 24 h of incubation (data not shown).
DISCUSSION
Fluid and electrolyte secretion into the intestinal lumen is a process that serves several functions. It promotes optimal 66 nutrient digestion and absorption, works in concert with mucins to protect the mucosa, and rids the gut of potentially noxious pathogens and toxins. To prevent excessive fluid losses, water and ions fluxes need to be finely tuned through effective braking mechanism (23). The present study provides evidence for the ability of the enterocyte to limit its own ion secretion through a mechanism that involves NO. The increase in I sc elicited by the NOS inhibitor L-NAME suggests that the intracellular NOS concentration produced in the enterocyte is essential to regulate basal transepithelial ion transport. L-NAME inhibition of NO production resulted in an increased cAMP concentration and I sc response, suggesting that in basal conditions NO maintains the intracellular concentration of cAMP at a low level. cAMP could therefore be the target of NO to regulate ion transport in the enterocyte.
The combined addition of CT and of L-NAME resulted in a significant increase in I sc compared with that obtained with CT alone, suggesting that NO is also effective in limiting active secretion. Again, the electrical effects were closely linked to cAMP intracellular concentration. Thus a close relationship exists between the modifications of cAMP and the NO effects on ion transport, both in basal conditions and in the presence of active secretion. This may be related to an inhibitory effect by NO on adenylate cyclase, similar to that described in human monocytes (24) . NO 2 Ϫ /NO 3 Ϫ determination and Western blot experiments contributed to clarifying the mechanisms of NO production and its role in response to cAMP-mediated ion secretion. The increased NO 2 Ϫ /NO 3 Ϫ production in response to CT or to 8Br-cAMP indicates that NO synthesis by the enterocyte is increased in response to stimulated secretion. NO overproduction was associ- 
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ated with an up-regulation of NOS 1 activity, as suggested by four distinct lines of evidence: 1) the time course of NO production in response to CT or 8Br-cAMP, whose rapid increase is typical of a cNOS rather than iNOS activity (2); 2) the Ca 2ϩ dependence of the effect, again typical of cNOS activity because it is known that the activity of iNOS is Ca 2ϩ /calmodulin-independent (2); 3) the lack of effect elicited by the specific inhibitor of iNOS (L-NIL) on NO production after stimulation with CT or 8Br-cAMP; and 4) the Western blot gels performed with specific anti-cNOS or anti-iNOS antibody, supporting the selective cNOS activation in response to CT or 8Br-cAMP. It has been suggested that upregulation of NOS 1 may be a component of the normal cellular stress response (25) . Thus expression levels of the low-output enzymes NOS 1 and NOS 3 may be adjusted to meet local demand (25) . Overall these findings are consistent with the concept of self-regulation of ion transport by the enterocyte, which operates in basal condition and, homeostatically, in conditions of stimulated secretion. In vivo evidence supporting the role of NO in a homeostatic mechanism comes from the increased levels of NO in both plasma and urine of patients with cholera (26) .
Our data are consistent with previous results by Beubler and Schirgi-Degen (27) reporting that i.v. administration of L-NAME enhanced CT-induced ion secretion in rat ligated jejunal loops, whereas the NO precursor L-arginine inhibited it. Similarly inhibition of endogenous NO synthesis by equimolar concentrations of L-NAME caused a secretory response of water and electrolytes in animal models (2, 28, 29) . However, others have reported that the NO substrate L-arginine induced electrogenic secretion in Caco-2 cells (18) . These apparently conflicting results may be explained by dose-related phenomena (2) . The concentration of L-arginine may play a crucial role in determining the proabsorptive or secretagogue effects. Wapnir et al. (30) have shown that low concentration of L-arginine, added to the oral rehydration solution, stimulates water and electrolyte absorption in the rat jejunum, whereas higher L-arginine concentrations induced a secretory shift of fluid and electrolyte transport. Alternatively, conflicting findings may be related to a species-specific effect of NO (for example, ileum versus human enterocytes), or to the nature of the specimens used (i.e. whole intestinal tissue, which contains inflammatory, neural, and endocrine-paracrine cells, all potential sources of NO) (31) .
The effects of NO in response to CT in Caco-2 cells resemble those observed with other secretagogues including prostaglandin E 2 , Escherichia coli heat-stable enterotoxin, and Clostridium difficile toxin A (27) , and suggest that NO is able to down-regulate fluid secretion elicited by different secretagogues, including those acting through intracellular mechanisms other than cAMP. This may suggest that NO is released in response to cyclic nucleotide concentration.
CONCLUSIONS
In conclusion, this work provided direct evidence that the enterocyte plays a direct role in the homeostatic regulation of its own ion transport processes, through the activation of the cNOS-NO pathway. This network functions as a braking force of ion secretion both in basal and in cAMP-stimulated conditions. The target of this effect is cAMP, which in turn triggers an increase in NOS 1 expression, likely to be interpreted as a homeostatic response.
